Incidence of venous thromboembolism during chemotherapy for breast cancer: Impact on cancer outcome

Anticancer Research

Volumn 31, Issue 6, 2011, Pages 2383-2388

  Kirwan, Cliona C ^a   Garry, Mcdowell ^b   Mccollum, Charles N ^a   Byrne, Gerard J ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Breast cancer; Chemotherapy; Outcome; Thromoboembolism

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; NAVELBINE; PROGESTERONE RECEPTOR;

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; VENOUS THROMBOEMBOLISM;

ADULT; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATORY BREAST NEOPLASMS; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 79960467239     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Andtbacka RH, Babiera G, Singletary SE, Hunt KK, Meric-Bernstam F, Feig BW, Ames FC, Ross MI, Dejesus Y and Kuerer HM: Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg 243(1): 96-101, 2006. (Pubitemid 43054060)
2. Lee AY and Levine MN: The thrombophilic state induced by therapeutic agents in the cancer patient. Semin Thromb Hemost 25(2): 137-145, 1999. (Pubitemid 29227142)
3. Saphner T, Tormey DC and Gray R: Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 9(2): 286-294, 1991.
4. Levine MN, Gent M, Hirsh J, Arnold A, Goodyear MD, Hryniuk W and De Pauw S: The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N Engl J Med 318(7): 404-407, 1988. (Pubitemid 18044179)
5. von Tempelhoff GF, Dietrich M, Hommel G and Heilmann L: Blood coagulation during adjuvant epirubicin/cyclophosphamide chemotherapy in patients with primary operable breast cancer. J Clin Oncol 14(9): 2560-2568, 1996. (Pubitemid 26300124)
6. Weiss RB, Tormey DC, Holland JF and Weinberg VE: Venous thrombosis during multimodal treatment of primary breast carcinoma. Cancer Treat Rep 65(7-8): 677-679, 1981. (Pubitemid 11046788)
7. Mandala M, Barni S, Prins M, Labianca R, Tondini C, Russo L, Milesi A, Cremonesi M, Zaccanelli M, Regonesi C, Moro C and Falanga A: Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial. Ann Oncol 21(4): 871-876, 2010.
8. Hall IE, Andersen MS, Krumholz HM and Gross CP: Predictors of venous thromboembolism in patients with advanced common solid cancers. J Cancer Epidemiol 2009: 182521, 2009.
9. Goodnough LT, Saito H, Manni A, Jones PK and Pearson OH: Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients. Cancer 54(7): 1264-1268, 1984. (Pubitemid 14003521)
10. Fotopoulou C, duBois A, Karavas AN, Trappe R, Aminossadati B, Schmalfeldt B, Pfisterer J and Sehouli J: Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. J Clin Oncol 26(16): 2683-2689, 2008.
11. Pritchard KI, Paterson AH, Paul NA, Zee B, Fine S and Pater J: Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group. J Clin Oncol 14(10): 2731-2737, 1996. (Pubitemid 26329659)
12. Sandhu R, Pan CX, Wun T, Harvey D, Zhou H, White RH and Chew HK: The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer. Cancer 116(11): 2596-2603, 2010.
13. Morgan MA, Iyengar TD, Napiorkowski BE, Rubin SC and Mikuta JJ: The clinical course of deep vein thrombosis in patients with gynecologic cancer. Gynecol Oncol 84(1): 67-71, 2002. (Pubitemid 34056469)
14. Chew HK, Wun T, Harvey D, Zhou H and White RH: Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 166(4): 458-464, 2006.
15. Chew HK, Wun T, Harvey DJ, Zhou H and White RH: Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J Clin Oncol 25(1): 70-76, 2007. (Pubitemid 350003053)
16. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET and Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6): 649-655, 1982. (Pubitemid 13149996)
17. Bressollette L, Nonent M, Oger E, Garcia JF, Larroche P, Guias B, Scarabin PY and Mottier D: Diagnostic accuracy of compression ultrasonography for the detection of asymptomatic deep venous thrombosis in medical patients - the TADEUS project. Thromb Haemost 86(2): 529-533, 2001. (Pubitemid 32743261)
18. Elias A, Cadene A, Elias M, Puget J, Tricoire JL, Colin C, Lefebvre D, Rousseau H and Joffre F: Extended lower limb venous ultrasound for the diagnosis of proximal and distal vein thrombosis in asymptomatic patients after total hip replacement. Eur J Vasc Endovasc Surg 27(4): 438-444, 2004. (Pubitemid 38386933)
19. Kassai B, Boissel JP, Cucherat M, Sonie S, Shah NR and Leizorovicz A: A systematic review of the accuracy of ultrasound in the diagnosis of deep venous thrombosis in asymptomatic patients. Thromb Haemost 91(4): 655-666, 2004. (Pubitemid 38488737)
20. Levine M, Hirsh J, Gent M, Arnold A, Warr D, Falanga A, Samosh M, Bramwell V, Pritchard KI, Stewart D and Goodwin P: Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 343(8902): 886-889, 1994. (Pubitemid 24113632)
21. Nolè F, Munzone E, Mandela M, Catania C, Orlando L, Zampino MG, Minchella I, Colleoni M, Peruzzotti G, Marrocco E and Goldhirsch A: Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: a phase II study. Ann Oncol 12(1): 95-100, 2001. (Pubitemid 32162453)
22. Clahsen PC, van de Velde CJ, Julien JP, Floiras JL and Mignolet FY: Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study. J Clin Oncol 12(6): 1266-1271, 1994.
23. Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P and Folsom AR: Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 117(1): 19-25, 2004. (Pubitemid 38801482)
24. Oberhoff C, Rollwagen C, Tauchert AM, Hoffmann O, Winkler UH and Schindler AE: Perioperative development of a thrombogenic risk profile in patients with carcinomas of the breast: a cause of increased thrombosis. Eur J Gynaecol Oncol 21(6): 560-568, 2000. (Pubitemid 32164818)
25. Rasmussen MS: Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis. Cancer Treat Rev 28(3): 141-144, 2002.
26. Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A and Dietrich-Neto F: Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346(13): 975-980, 2002.
27. Rasmussen MS: Does prolonged thromboprophylaxis improve outcome in patients undergoing surgery? Cancer Treat Rev 29(Suppl 2): 15-17, 2003.
28. Ludwig Breast Cancer Study Group: Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 320(8): 491-496, 1989.
29. Sorensen HT, Mellemkjaer L, Olsen JH and Baron JA: Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343(25): 1846-1850, 2000.
30. Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R and Rimm AA: Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 78(5): 285-291, 1999.
31. Seward J, Byrne GJ, Howell A, Bundred NJ and McCollum CN: Does cytotoxic chemotherapy precipitate venous thromboembolism in patients with cancer? Breast Cancer ResTreat 57: 57, 1999.
32. Lyman GH: Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis. Cancer 117(7): 1334-1349, 2011.
33. Blom JW, Osanto S and Rosendaal FR: The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. J Thromb Haemost 2(10): 1760-1765, 2004. (Pubitemid 40192717)
34. den Exter PL, Hooijer J, Dekkers OM and Huisman MV: Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: A comparison with symptomatic patients. J Clin Oncol, 2011.